site stats

Thomas schuetz compass therapeutics

WebDr. Schuetz co-founded Compass in 2014 following conceptual discussions while he was Venture Partner at Orbimed. As a physician-scientist and serial entrepreneur, he aspired to create an antibody therapeutic company based on novel biology, protein engineering and key medical insights gathered throughout his career. WebMar 4, 2024 · About Compass Therapeutics. Compass Therapeutics, Inc. (OTCQB: CMPX), is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics …

Compass Therapeutics, Inc. to Acquire TRIGR Therapeutics, Inc.

WebApr 13, 2024 · Compass Therapeutics already has institutions on the share registry. ... In addition, we found that Thomas Schuetz, the CEO has 4.0% of the shares allocated to their name. WebApr 11, 2024 · Insider Activity at Compass Therapeutics. In other news, CEO Thomas J. Schuetz purchased 20,000 shares of the business’s stock in a transaction dated Tuesday, January 31st. ウェスタンデジタル hdd https://martinwilliamjones.com

Compass Therapeutics公司简介 - Moomoo

WebJan 26, 2024 · Whilst it may not be a huge deal, we thought it was good to see that the Compass Therapeutics, Inc. (NASDAQ:CMPX) Co-Founder, Thomas Schuetz, recently … WebPresently, he holds the position of Chief Executive Officer & Director at Compass Therapeutics, Inc. and Manager at Compass Therapeutics LLC (a subsidiary of Compass … WebThomas Schuetz Cloud Native Engineer, Advocate ... Thomas Schuetz CEO at Compass Therapeutics LLC Greater Boston. 37 others named Thomas … pago semaforizacion bogota

Compass Therapeutics LLC Management Team Org Chart

Category:Compass Therapeutics LLC Management Team Org Chart

Tags:Thomas schuetz compass therapeutics

Thomas schuetz compass therapeutics

Compass Therapeutics, Inc. (NASDAQ:CMPX) CEO Thomas J.

WebJan 10, 2024 · The first patient has been dosed in the phase 2 study (NCT05513742) of CTX-009 given in the third- or fourth-line setting to patients with metastatic colorectal cancer, according to Compass Therapeutics, Inc. 1 CTX-009 is a bispecific antibody which works by simultaneously blocking Delta-like ligand 4/Notch and vascular endothelial growth factor … WebThomas J. Schuetz, M.D., Ph.D. Chief Executive Officer Compass Therapeutics, Inc. 80 Guest Street Suite 601 Boston, MA 02135 Re: Compass Therapeutics, Inc. Registration …

Thomas schuetz compass therapeutics

Did you know?

WebGet Thomas Schuetz's email address (t*****@compasstherapeutics.com) and phone number (914980....) at RocketReach. Get 5 free searches. ... Top Compass Therapeutics … WebApr 11, 2024 · In other Compass Therapeutics news, CEO Thomas J. Schuetz bought 20,000 shares of the company's stock in a transaction that occurred on Tuesday, January 31st. …

Web“This transaction provides the resources necessary to advance our lead program, CTX-471,through clinical development, advance our second program, CTX-8371, to the clinic … WebThomas J. Schuetz, MD, PhD has over 20 ... He co-founded Compass in 2014 following conceptual discussions while he was a venture partner at OrbiMed. While at OrbiMed, …

WebApr 11, 2024 · Insider Activity at Compass Therapeutics. In other news, CEO Thomas J. Schuetz purchased 20,000 shares of the business’s stock in a transaction dated Tuesday, … WebNov 18, 2024 · Learn about working at COMPASS THERAPEUTIC from employee reviews and detailed data on culture, salaries, demographics, management, ... Thomas J. Schuetz. Errik B. Anderson. See All CEO & Executives. COMPASS THERAPEUTIC Salaries. 8.6. Salary Score. Average COMPASS THERAPEUTIC Salary. $44,823.

WebUnited States securities and exchange commission logo August 10, 2024 Thomas J. Schuetz, M.D., Ph.D. Chief Executive Officer Compass Therapeutics, Inc. 245 First Street …

WebApr 13, 2024 · Compass Therapeutics already has institutions on the share registry. ... In addition, we found that Thomas Schuetz, the CEO has 4.0% of the shares allocated to … pago semarnat e5cincoWebThomas Schuetz - Ceo - Compass Therapeutics Llc - email id & phone of top management contacts like Founder, CEO, CFO, CMO, CTO, Marketing or HR or Finance head. ウエスタンデジタル hdd 型番WebFeb 27, 2024 · SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL … ウエスタンデジタル hddWebThomas J Schuetz is CEO/Co-Founder at Compass Therapeutics LLC. See Thomas J Schuetz's compensation, career history, education, & memberships. ウェスタンデジタル hdd 評判WebThomas J. Schuetz, MD, PhD Co-founder and Chief Executive Officer, Compass Therapeutics He co-founded Compass in 2014 following conceptual discussions while he … ウエスタンデジタル hdd 色の違いWebApr 11, 2024 · Also, CEO Thomas J. Schuetz purchased 10,000 shares of Compass Therapeutics stock in a transaction on Friday, March 10th. The shares were acquired at an average cost of $3.37 per share, for a ... pago seremiWebJun 23, 2024 · Compass Therapeutics closed a $60 million private placement financing as well as completed a reverse merger transaction with Olivia Ventures, Inc. ウエスタンデジタル キオクシア